Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
764.00    -4.00 (-0.52%)
Bid:
763.00
Ask:
764.50
Spread: 1.50 (0.197%)
Market Cap: £1.54b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Director/PDMR Shareholding

6 Dec 2023 11:00

RNS Number : 8944V
Dunelm Group plc
06 December 2023
 

6 December 2023

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS EXERCISING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

Dunelm Group plc (the "Company") has been notified that on 5 December 2023, Nick Wilkinson, Chief Executive Officer, exercised 88,477 nil cost options over ordinary shares of one pence each in the Company. These options were granted to him on 20 November 2020 under the terms of the Dunelm Group 2014 Long Term Incentive Plan. Mr Wilkinson has sold 41,710 ordinary shares at a price of 1049p per share to fund the tax and national insurance due in connection with this exercise.

 

For further information please contact: 

 

Dunelm Group plc

Luisa Wright/Simon Hockridge

 

 

InvestorRelations@dunelm.com

 

 

MHP Communications

 

 

Rachel Farrington/Charles Hirst

 

 

dunelm@mhpc.com

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Nick Wilkinson

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Dunelm Group plc

b)

 

LEI

 

213800WCOWEI3T5DUV19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of one pence each 

 

 

ISINGB00BICQ739

 

b)

 

Nature of the transaction

 

 

1. Exercise of nil cost options under the Long-Term Incentive Plan

2. Sale of shares to fund income tax and national insurance liability on exercise of such award

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

Exercise of options: 88,477

£10.49

Shares sold: 41,710

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

1. 88,477

2. 41,710

 

 

1. Nil

2. £10.49

e)

 

Date of the transaction

 

 

2023.12.05

f)

 

Place of the transaction

 

 

1. Outside a trading venue

2. London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKABPKBDDBBK
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
12th May 20267:00 amRNSDirector/PDMR Shareholding
8th May 20263:27 pmRNSDirector/PDMR Shareholding - Replacement
8th May 202611:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSThird quarter trading update
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20263:24 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSPurchases of Shares During Open Periods
13th Feb 202611:00 amRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSInterim Results
2nd Feb 20267:00 amRNSTotal Voting Rights
15th Jan 20267:00 amRNSSecond quarter and first half trading update
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
9th Dec 20257:00 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSPDMR Shareholding
28th Nov 20257:00 amRNSTotal Voting Rights
25th Nov 202510:14 amRNSDirector/PDMR Shareholding Amendment
25th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20252:30 pmRNSResult of AGM
11th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
31st Oct 20259:52 amRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFirst quarter trading statement
9th Oct 202510:00 amRNSNotice of AGM, Annual Report and Accounts
8th Oct 20257:00 amRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.